An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
The Subject Expert Committee (SEC) will hold a meeting today to take a final call on allowing booster doses of Covid-19 vaccines amid the growing Omicron threat, news agency ANI reported.
Recently, states like Kerala, Rajasthan, Karnataka and Chhattisgarh urged the Centre to decide on allowing booster doses of COVID-19 vaccine amid concerns raised by 'Omicron'.
Dr Reddy's Laboratories has sought permission from India's drug regulator to conduct a phase-3 clinical trial to evaluate the efficacy and safety of Sputnik Light vaccine as a booster dose against Covid-19 in India, sources said on Thursday.